Animal models of chemotherapy-evoked painful peripheral neuropathies

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Neurotherapeutics

• Publication date

  2009-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.nurt.2009.07.003PMID 19789067PMCID PMC5084284
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Peripheral Neuropathy

  2019cited by this paper
• Neurotropin reverses paclitaxel-induced neuropathy without affecting anti-tumour efficacy.

  2009cited by this paper
• Effects of the prostaglandin E1 analog limaprost on mechanical allodynia caused by chemotherapeutic agents in mice.

  2009influential reference
• Central and peripheral nervous system toxicity of common chemotherapeutic agents

  2009cited by this paper
• Mechanical allodynia induced by paclitaxel, oxaliplatin and vincristine: different effectiveness of gabapentin and different expression of voltage-dependent calcium channel alpha(2)delta-1 subunit.

  2009cited by this paper
• Ganglioside GM1 (porcine) ameliorates paclitaxel-induced neuropathy in rats.

  2009cited by this paper
• Docetaxel‐induced peripheral neuropathy: protective effects of dihydroprogesterone and progesterone in an experimental model

  2009cited by this paper
• Comparison of oxaliplatin- and cisplatin-induced painful peripheral neuropathy in the rat.

  2009cited by this paper
• Herbal medicine Shakuyaku‐kanzo‐to reduces paclitaxel‐induced painful peripheral neuropathy in mice

  2009influential reference
• Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli

  2009cited by this paper
• Involvement of increased expression of transient receptor potential melastatin 8 in oxaliplatin-induced cold allodynia in mice.

  2009influential reference
• Antinociceptive and anti-allodynic effects of oral PL37, a complete inhibitor of enkephalin-catabolizing enzymes, in a rat model of peripheral neuropathic pain induced by vincristine.

  2008cited by this paper
• The critical role of invading peripheral macrophage-derived interleukin-6 in vincristine-induced mechanical allodynia in mice.

  2008cited by this paper
• Interaction of Transient Receptor Potential Vanilloid 4, Integrin, and Src Tyrosine Kinase in Mechanical Hyperalgesia

  2008cited by this paper
• Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy.

  2008cited by this paper
• Ameliorative effects of amiloride and pralidoxime in chronic constriction injury and vincristine induced painful neuropathy in rats.

  2008cited by this paper
• Alpha(1) and alpha(2)-adrenoreceptor antagonists in streptozotocin- and vincristine-induced hyperalgesia.

  2008cited by this paper
• Ghrelin prevents cisplatin-induced mechanical hyperalgesia and cachexia.

  2008cited by this paper
• Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity

  2008cited by this paper
• Chemotherapy‐induced neuropathy

  2008cited by this paper
• Serotonin 5‐HT2A receptor involvement and Fos expression at the spinal level in vincristine‐induced neuropathy in the rat

  2008cited by this paper
• Behavioral and electrophysiological studies in rats with cisplatin-induced chemoneuropathy.

  2008cited by this paper
• Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies.

  2008cited by this paper
• Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats

  2008cited by this paper
• Ixabepilone: a novel microtubule inhibitor for the treatment of locally advanced or metastatic breast cancer.

  2008cited by this paper
• Specific Antinociceptive Activity of Cholest-4-en-3-one, Oxime (TRO19622) in Experimental Models of Painful Diabetic and Chemotherapy-Induced Neuropathy

  2008influential reference
• Experimental studies of potential analgesics for the treatment of chemotherapy-evoked painful peripheral neuropathies.

  2008cited by this paper
• MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models

  2008cited by this paper
• Effect of cyclooxygenase and nitric oxide synthase inhibitors on vincristine induced hyperalgesia in rats.

  2008cited by this paper
• Neuropathy associated with microtubule inhibitors: diagnosis, incidence, and management.

  2008cited by this paper
• Comparative antiallodynic activity of morphine, pregabalin and lidocaine in a rat model of neuropathic pain produced by one oxaliplatin injection.

  2008cited by this paper
• Animal models of cancer pain.

  2008cited by this paper
• Neurologic complications of chemotherapy agents

  2007cited by this paper
• Behavioral and immunohistological assessment of painful neuropathy induced by a single oxaliplatin injection in the rat.

  2007cited by this paper
• WIN 55,212-2 prevents mechanical allodynia but not alterations in feeding behaviour induced by chronic cisplatin in the rat.

  2007cited by this paper
• Behavioral and pharmacological description of oxaliplatin‐induced painful neuropathy in rat

  2007influential reference
• Chemotherapy-evoked painful peripheral neuropathy: analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit.

  2007cited by this paper
• Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats

  2007cited by this paper
• Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth.

  2007cited by this paper
• Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats.

  2007cited by this paper
• Therapeutic efficacy of prosaposin‐derived peptide on different models of allodynia

  2006cited by this paper
• Management of chemotherapy-induced peripheral neuropathy

  2006cited by this paper
• Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells.

  2006cited by this paper
• Neurological complications of cancer chemotherapy

  2006cited by this paper
• Clinical and experimental findings in humans and animals with chemotherapy-induced peripheral neuropathy.

  2006cited by this paper
• Protective Effect of Erythropoietin and Its Carbamylated Derivative in Experimental Cisplatin Peripheral Neurotoxicity

  2006cited by this paper
• Inhibition of Paclitaxel-Induced A-Fiber Hypersensitization by Gabapentin

  2006cited by this paper
• Propentofylline attenuates vincristine-induced peripheral neuropathy in the rat.

  2006cited by this paper
• Studies of peripheral sensory nerves in paclitaxel‐induced painful peripheral neuropathy: Evidence for mitochondrial dysfunction

  2006cited by this paper
• Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy.

  2006cited by this paper
• Acetyl-L-Carnitine prevents and reverts experimental chronic neurotoxicity induced by oxaliplatin, without altering its antitumor properties.

  2005cited by this paper
• Possible involvement of the spinal nitric oxide/cGMP pathway in vincristine‐induced painful neuropathy in mice

  2005cited by this paper
• Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats.

  2005cited by this paper
• A cannabinoid agonist, WIN 55,212‐2, reduces neuropathic nociception induced by paclitaxel in rats

  2005cited by this paper
• What should we be measuring in behavioral studies of chronic pain in animals?

  2004cited by this paper
• Effect of leukemia inhibitory factor in experimental cisplatin neuropathy in mice.

  2004cited by this paper
• Cytokine and chemokine expression profiles of maturing dendritic cells using multiprotein platform arrays.

  2004cited by this paper
• Ethosuximide reverses paclitaxel‐ and vincristine‐induced painful peripheral neuropathy

  2004cited by this paper
• Cyclooxygenase inhibitors and thalidomide ameliorate vincristine-induced hyperalgesia in rats

  2004cited by this paper
• Experimental cisplatin neuronopathy in rats and the effect of retinoic acid administration

  2004cited by this paper
• Attenuation of mechanical allodynia by clinically utilized drugs in a rat chemotherapy‐induced neuropathic pain model

  2004cited by this paper
• Changes in sensory processing in the spinal dorsal horn accompany vincristine‐induced hyperalgesia and allodynia

  2003cited by this paper
• A new animal model of vincristine-induced nociceptive peripheral neuropathy.

  2003cited by this paper
• Evidence for an antihyperalgesic effect of venlafaxine in vincristine-induced neuropathy in rat.

  2003cited by this paper
• An animal model of nociceptive peripheral neuropathy following repeated cisplatin injections.

  2003cited by this paper
• Altered temporal pattern of evoked afferent activity in a rat model of vincristine-induced painful peripheral neuropathy.

  2003cited by this paper
• Wlds mice are resistant to paclitaxel (taxol) neuropathy

  2002cited by this paper
• A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel

  2001influential reference
• Role of protein kinase Cϵ and protein kinase A in a model of paclitaxel-induced painful peripheral neuropathy in the rat

  2001cited by this paper
• The experimental neuroprotectant leukaemia inhibitory factor (LIF) does not compromise antitumour activity of paclitaxel, cisplatin and carboplatin

  2001cited by this paper
• Vincristine‐induced allodynia in the rat

  2001cited by this paper
• Evidence that nerve growth factor promotes the recovery of peripheral neuropathy induced in mice by cisplatin: behavioral, structural and biochemical analysis.

  2000influential reference
• Description of a short-term Taxol-induced nociceptive neuropathy in rats.

  2000influential reference
• Assessment of allodynia and hyperalgesia after cisplatin administration to rats.

  2000cited by this paper
• Physiological and immunohistochemical characterization of cisplatin‐induced neuropathy in mice

  1999cited by this paper
• Pain related behaviour during vincristine-induced neuropathy in rats.

  1999influential reference
• Physiological characterization of taxol‐induced large‐fiber sensory neuropathy in the rat

  1998cited by this paper
• Nociceptor Hyper-Responsiveness during Vincristine-Induced Painful Peripheral Neuropathy in the Rat

  1998cited by this paper
• Prosaptide prevents paclitaxel neurotoxicity.

  1998cited by this paper
• Microtubule disorientation and axonal swelling in unmyelinated sensory axons during vincristine‐induced painful neuropathy in rat

  1998cited by this paper
• Insulin-like growth factor-I prevents development of a vincristine neuropathy in mice.

  1997influential reference
• Effect on the peripheral nervous system of the short-term intravenous administration of paclitaxel in the rat.

  1997cited by this paper
• Vincristine hyperalgesia in the rat: a model of painful vincristine neuropathy in humans.

  1996cited by this paper
• Glutamate ameliorates experimental vincristine neuropathy.

  1996cited by this paper
• Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol.

  1995cited by this paper
• Nerve growth factor prevents experimental cisplatin neuropathy

  1992cited by this paper
• Nerve growth factor prevents toxic neuropathy in mice

  1991cited by this paper
• “Model”

  1981cited by this paper

• Antisense Oligonucleotide of cargo adaptor BICD2 Long-Term Effectively Alleviates Neuropathic Pain via Activation of PSD95 in the Mouse Spinal Dorsal Horn.

  2025cites this paper
• Downregulation of collagen and elastin genes in murine skin following cisplatin and vincristine treatment.

  2025cites this paper
• Delta-9-tetrahydrocannabinol and Cannabidiol for Pain: Preclinical and Clinical Models.

  2025cites this paper
• An Enhanced Cancer Immunogenic Cell Death Strategy: Fibrate-Oxaliplatin(IV) Conjugates with Modulating Tumor Immune Microenvironment.

  2025cites this paper
• Colorectal Cancer at the Crossroads: The Good, the Bad, and the Future of Platinum-Based Drugs

  2025cites this paper
• Navigating Preclinical Models and Medications for Peripheral Neuropathy: A Review

  2024cites this paper
• Animal models of neuropathic pain.

  2024cites this paper
• The challenge to identify sensitive safety biomarkers of peripheral neurotoxicity in the rat: a collaborative effort across industry and academia (IMI NeuroDeRisk project).

  2024cites this paper
• Complications and comorbidities associated with antineoplastic chemotherapy: Rethinking drug design and delivery for anticancer therapy

  2024cites this paper
• Exploring Serum Biomarkers for Neuropathic Pain in Rat Models of Chemotherapy-Induced Peripheral Neuropathy: A Comparative Pilot Study with Oxaliplatin, Paclitaxel, Bortezomib, and Vincristine

  2023influential citation
• Oxidative Damage as a Fundament of Systemic Toxicities Induced by Cisplatin—The Crucial Limitation or Potential Therapeutic Target?

  2023cites this paper
• Microglial P2Y12 Signaling Contributes to Cisplatin-induced Pain Hypersensitivity via IL-18-mediated Central Sensitization in the Spinal Cord.

  2023cites this paper
• Daidzein attenuated paclitaxel-induced neuropathic pain via the down-regulation of TRPV1/P2Y and up-regulation of Nrf2/HO-1 signaling

  2023cites this paper
• Intrathecal rapamycin attenuates the mechanical hyperalgesia of paclitaxel-induced peripheral neuropathy in mice

  2023cites this paper
• Blockade of Cholecystokinin Type 2 Receptors Prevents the Onset of Vincristine-Induced Neuropathy in Mice

  2022cites this paper
• Chemotherapy induced gastrointestinal toxicities.

  2022cites this paper
• A synthetic prostaglandin E1 analogue, misoprostol, ameliorates paclitaxel-induced oxidative damage in rat brain.

  2022cites this paper
• Paeoniflorin Ameliorates BiPN by Reducing IL6 Levels and Regulating PARKIN-Mediated Mitochondrial Autophagy

  2022cites this paper
• Glial and neuroimmune cell choreography in sexually dimorphic pain signaling.

  2021cites this paper
• Probing the peripheral immune response in mouse models of oxaliplatin-induced peripheral neuropathy highlights their limited translatability

  2021cites this paper
• Mechanisms of peripheral neurotoxicity associated with four chemotherapy drugs using human induced pluripotent stem cell-derived peripheral neurons.

  2021cites this paper
• Title: Drosophila model of Anti-retroviral therapy Induced Peripheral Neuropathy and Nociceptive Hypersensitivity

  2020cites this paper
• A Comparative Review of Chemotherapy-Induced Peripheral Neuropathy in In Vivo and In Vitro Models

  2020cites this paper
• Insights into platinum-induced peripheral neuropathy–current perspective

  2020cites this paper
• Drosophila model of anti-retroviral therapy induced peripheral neuropathy and nociceptive hypersensitivity

  2020cites this paper
• NYX-2925, A NOVEL, NON-OPIOID, SMALL-MOLECULE MODULATOR OF THE N-METHYL-d-ASPARTATE RECEPTOR (NMDAR), DEMONSTRATES POTENTIAL TO TREAT CHRONIC, SUPRASPINAL CENTRALIZED PAIN CONDITIONS

  2020cites this paper
• FLOX (5-fluorouracil + leucovorin + oxaliplatin) chemotherapy for colorectal cancer leads to long-term orofacial neurotoxicity: a STROBE-guided longitudinal prospective study

  2020cites this paper
• Essential References for Structural Analysis of the Peripheral Nervous System for Pathologists and Toxicologists

  2020cites this paper
• Vortioxetine reduces pain hypersensitivity and associated depression-like behavior in mice with oxaliplatin-induced neuropathy.

  2020cites this paper
• Neurotoxicity of antineoplastic drugs: Mechanisms, susceptibility, and neuroprotective strategies.

  2020cites this paper
• The Study of Pain in Rats and Mice.

  2019cites this paper
• Is TRPA1 Burning Down TRPV1 as Druggable Target for the Treatment of Chronic Pain?

  2019cites this paper
• A Comparative Study between the Effect of Nerve Growth Factor and All-Trans Retinoic Acid versus their combined use on Taxol Induced Peripheral Neuropathy in Adult Male Albino Rat

  2019cites this paper
• Peripheral and central oxidative stress in chemotherapy-induced neuropathic pain

  2019cites this paper
• Subacute toxicity and toxicokinetics study of DHP107, an oral paclitaxel formulation with once‐weekly dosing in mice

  2019cites this paper
• Neurosteroids and Neuropathic Pain Management: basic evidence and therapeutic perspectives.

  2019cites this paper
• Identification of a Potent Tryptophan-Based TRPM8 Antagonist With in Vivo Analgesic Activity.

  2018cites this paper
• Blocking of cytokines signalling attenuates evoked and spontaneous neuropathic pain behaviours in the paclitaxel rat model of chemotherapy‐induced neuropathy

  2018cites this paper
• Small-fiber neuropathy and pain sensitization in survivors of pediatric acute lymphoblastic leukemia.

  2018cites this paper
• Antinociceptive effectiveness of Tithonia tubaeformis in a vincristine model of chemotherapy-induced painful neuropathy in mice.

  2018cites this paper
• Enriched Environment and Effects on Neuropathic Pain: Experimental Findings and Mechanisms

  2018cites this paper
• Gaps in Understanding Mechanism and Lack of Treatments: Potential Use of a Nonhuman Primate Model of Oxaliplatin-Induced Neuropathic Pain

  2018cites this paper
• Beneficial effects of Gelsemium-based treatment against paclitaxel-induced painful symptoms

  2018cites this paper
• Behavioral and electromyographic assessment of oxaliplatin‐induced motor dysfunctions: Evidence for a therapeutic effect of allopregnanolone

  2017cites this paper
• The chemotherapeutic agent paclitaxel selectively impairs reversal learning while sparing prior learning, new learning and episodic memory.

  2017cites this paper
• Pharmacological augmentation of nicotinamide phosphoribosyltransferase (NAMPT) protects against paclitaxel-induced peripheral neuropathy

  2017cites this paper
• Animal models of chronic pain: Advances and challenges for clinical translation

  2017cites this paper
• Evaluating the Significance Alleviation of Protective drugs on Cisplatininducedneurotoxicity on Sciatic nerves of rats

  2017cites this paper
• Application of stem cell derived neuronal cells to evaluate neurotoxic chemotherapy.

  2017cites this paper
• Therapeutic potential of certain drug combinations on paclitaxel-induced peripheral neuropathy in rats.

  2017cites this paper
• Roles of Transient Receptor Potential Ankyrin 1 in Oxaliplatin-Induced Peripheral Neuropathy.

  2017cites this paper
• Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): a narrative review

  2017cites this paper
• Axonopathy in peripheral neuropathies: Mechanisms and therapeutic approaches for regeneration.

  2016cites this paper
• Sustained Accumulation of Microtubule-Binding Chemotherapy Drugs in the Peripheral Nervous System: Correlations with Time Course and Neurotoxic Severity.

  2016cites this paper
• Progress in study of Cannabis sativa leaves extracts without psychotropic cannabinoids in animal model of neuropathic pain

  2016cites this paper
• 9. Utilization of In Vitro Neurotoxicity Models in Pre-Clinical Toxicity Assessment

  2016cites this paper
• Tracking Epidermal Nerve Fiber Changes in Asian Macaques

  2016cites this paper
• Pharmacological comparison of a nonhuman primate and a rat model of oxaliplatin‐induced neuropathic cold hypersensitivity

  2016cites this paper
• A Systematic Review on Neuropathy

  2016cites this paper
• Chemotherapy-Induced Peripheral Neuropathic Pain and Rodent Models.

  2016cites this paper
• Pathomechanismen und Präventionsstrategien Chemotherapie induzierter Neuropathien

  2016cites this paper
• Synergistic neroprotective activiity of benfotiamine co administered with erythropoietin in chemotherapy induced peripheral neuropathy in rats

  2015cites this paper
• Effect of Gabapentin and Pregabalin in Rat Model of Taxol Induced Neuropathic Pain.

  2015cites this paper
• Modeling Chemotherapeutic Neurotoxicity with Human Induced Pluripotent Stem Cell-Derived Neuronal Cells

  2015cites this paper
• A New Rat Model of Cisplatin-induced Neuropathic Pain

  2015cites this paper
• [Chemotherapy-induced Peripheral Neuropathy].

  2015cites this paper
• Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives

  2015cites this paper
• Thyroxine: a putative neuroprotectant in chemotherapy induced peripheral neuropathy in rats

  2015cites this paper
• Antinociceptive activity of transient receptor potential channel TRPV1, TRPA1, and TRPM8 antagonists in neurogenic and neuropathic pain models in mice

  2015cites this paper
• Animal Models for the Study of Comorbid Pain and Psychiatric Disorders.

  2015cites this paper
• Eribulin Mesylate: Mechanism of Action of a Unique Microtubule-Targeting Agent

  2015cites this paper
• Circuitry and plasticity of the dorsal horn--toward a better understanding of neuropathic pain.

  2015cites this paper
• Optimization of a cisplatin model of chemotherapy-induced peripheral neuropathy in mice: use of vitamin C and sodium bicarbonate pretreatments to reduce nephrotoxicity and improve animal health status

  2014cites this paper
• Behavioral pharmacology of pain.

  2014cites this paper
• Specific targeting of neurotoxic side effects and pharmacological profile of the novel cancer stem cell drug salinomycin in mice

  2014cites this paper
• Monocytes expressing CX3CR1 orchestrate the development of vincristine-induced pain.

  2014cites this paper
• Pain in cancer survivors.

  2014cites this paper
• Institutional animal care and use committee considerations for animal models of peripheral neuropathy.

  2014cites this paper
• Optimization and pharmacological characterization of a refined cisplatin-induced rat model of peripheral neuropathic pain

  2014cites this paper
• Potential role of allopregnanolone for a safe and effective therapy of neuropathic pain.

  2014cites this paper
• Neurochemical characterization of primary sensory neurons in a rat model of bortezomic-induced peripheral neuropathy

  2014cites this paper
• Antiallodynic and antihyperalgesic activity of 3-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one compared to pregabalin in chemotherapy-induced neuropathic pain in mice.

  2014cites this paper
• Electrophysiological, behavioral and histological characterization of paclitaxel, cisplatin, vincristine and bortezomib-induced neuropathy in C57Bl/6 mice

  2014influential citation
• Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain

  2014cites this paper
• Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery

  2014cites this paper
• Emerging Trends in Understanding Chemotherapy-Induced Peripheral Neuropathy

  2013cites this paper
• NON-INVASIVE EVALUATION OF NERVE CONDUCTION IN SMALL DIAMETER FIBERS IN THE RAT.

  2013cites this paper
• Neuropathy-Inducing Effects of Eribulin Mesylate Versus Paclitaxel in Mice with Preexisting Neuropathy

  2013cites this paper
• Use of sodium bicarbonate to promote weight gain, maintain body temperature, normalize renal functions and minimize mortality in rodents receiving the chemotherapeutic agent cisplatin.

  2013cites this paper
• Herbal Medicine Goshajinkigan Prevents Paclitaxel-Induced Mechanical Allodynia without Impairing Antitumor Activity of Paclitaxel

  2013cites this paper
• Neurosteroid 3α-Androstanediol Efficiently Counteracts Paclitaxel-Induced Peripheral Neuropathy and Painful Symptoms

  2013cites this paper
• Assessment of Paclitaxel Induced Sensory Polyneuropathy with “Catwalk” Automated Gait Analysis in Mice

  2013cites this paper
• The antioxidant effects of the flavonoids rutin and quercetin inhibit oxaliplatin-induced chronic painful peripheral neuropathy

  2013cites this paper
• Preclinical evidence for the antihyperalgesic activity of CDP-choline in oxaliplatin-induced neuropathic pain.

  2013cites this paper
• Toxic and drug-induced peripheral neuropathies: updates on causes, mechanisms and management

  2013cites this paper
• Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.

  2013cites this paper
• The therapeutic potential of Rho GTPase intervention

  2013cites this paper
• Pregabalin attenuates docetaxel-induced neuropathy in rats

  2012cites this paper
• Synthesis and biological evaluation of 2-amino-1-thiazolyl imidazoles as orally active anticancer agents

  2012cites this paper
• Traitement de la douleur à l'aide de cellules souches placentaires

  2012cites this paper